Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-010-0790-6.

Title:
Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma | Breast Cancer Research and Treatment
Description:
HAb18G is a recently identified hepatoma-associated antigen and its association with tumor growth, invasion, and angiogenesis has been studied in a variety of tumors. However, its role in the tumor progression of breast cancer has not been explored. HAb18G expression was examined by immunohistochemistry in pathological sections of 1,637 breast tissue samples and by in situ hybridization in 41 cases of invasive breast carcinomas (BC). While not detected in any cases of tumor-like conditions or benign tumors of breast, and only rarely in normal tissue (4.4%), HAb18G expression was gradually up-regulated from atypical ductal hyperplasia (27.3%), to ductal carcinoma-in situ (59.8%), and to BC (61.4%) (P < 0.01). Its expression in BC was correlated positively with C-erbB-2 expression and histologic grade (P < 0.001), and negatively with the expression of estrogen and progesterone receptors (P < 0.001). Significant differences of expression were also identified among the subgroups of BC examined: in decreasing order from invasive micropapillary carcinoma, ductal carcinoma, lobular carcinoma, papillary carcinoma, medullary carcinoma, to mucinous adenocarcinoma (P = 0.001), corresponding to their known clinical aggressiveness. In an expanded group of 186 BC patients with proper follow up, our previous findings were confirmed: HAb18G expression was significantly associated with local recurrence, distant metastasis and tumor mortality (P < 0.01). We also demonstrated that up-regulated tumor expression of HAb18G was a significant predictor of reduced disease progression-free survival rate and a shorter overall survival, independent of systemic therapies. In conclusion, this study suggests that HAb18G expression is associated with BC progression and prognosis. Further evaluation of this new marker in breast cancer is indicated.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

article, cancer, chen, google, scholar, pubmed, breast, cas, carcinoma, expression, zhang, habg, tumor, research, mmp, prognosis, human, liu, invasion, metastasis, cell, hepatocellular, privacy, cookies, content, progression, cui, yang, wang, access, habgcd, biol, information, publish, search, growth, significant, hepatoma, zhou, qian, matrix, int, oncol, china, university, laboratory, data, log, journal, fangfang,

Topics {✒️}

month download article/chapter hab18g/cd147-mediated calcium mobilization store-operated calcium entry breast cancer research full article pdf privacy choices/manage cookies innovative research team ronggang lang related subjects tumor cell surface breast cancer pathology human prostate cancer invasive breast carcinomas 4t1 breast carcinoma state key laboratory hepatoma metastasis require regulated tumor expression chinese patent zl01131735 isolating human antibody european economic area monoclonal antibody hab18 attenuates adhesion ability randomized controlled trial binds interstitial collagenase female genital organs significant prognostic factors invasive micropapillary carcinoma human hepatoma cells human hepatocellular carcinoma li fu n-terminal domains atypical ductal hyperplasia electronic supplementary material matrix metalloproteinase synthesis author information authors tianjin medical university temple university hospital article liu accepting optional cookies hepatocellular carcinoma cells zhinan chen check access migration involves expression instant access emmprin predicts prognosis recently identified hepatoma preventing hepatoma recurrence breast cancer research laboratory conditions privacy policy

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma
         description:HAb18G is a recently identified hepatoma-associated antigen and its association with tumor growth, invasion, and angiogenesis has been studied in a variety of tumors. However, its role in the tumor progression of breast cancer has not been explored. HAb18G expression was examined by immunohistochemistry in pathological sections of 1,637 breast tissue samples and by in situ hybridization in 41 cases of invasive breast carcinomas (BC). While not detected in any cases of tumor-like conditions or benign tumors of breast, and only rarely in normal tissue (4.4%), HAb18G expression was gradually up-regulated from atypical ductal hyperplasia (27.3%), to ductal carcinoma-in situ (59.8%), and to BC (61.4%) (P < 0.01). Its expression in BC was correlated positively with C-erbB-2 expression and histologic grade (P < 0.001), and negatively with the expression of estrogen and progesterone receptors (P < 0.001). Significant differences of expression were also identified among the subgroups of BC examined: in decreasing order from invasive micropapillary carcinoma, ductal carcinoma, lobular carcinoma, papillary carcinoma, medullary carcinoma, to mucinous adenocarcinoma (P = 0.001), corresponding to their known clinical aggressiveness. In an expanded group of 186 BC patients with proper follow up, our previous findings were confirmed: HAb18G expression was significantly associated with local recurrence, distant metastasis and tumor mortality (P < 0.01). We also demonstrated that up-regulated tumor expression of HAb18G was a significant predictor of reduced disease progression-free survival rate and a shorter overall survival, independent of systemic therapies. In conclusion, this study suggests that HAb18G expression is associated with BC progression and prognosis. Further evaluation of this new marker in breast cancer is indicated.
         datePublished:2010-03-09T00:00:00Z
         dateModified:2010-03-09T00:00:00Z
         pageStart:677
         pageEnd:688
         sameAs:https://doi.org/10.1007/s10549-010-0790-6
         keywords:
            HAb18G
            Breast carcinoma
            Immunohistochemistry
            Tumor progression
            Prognosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-0790-6/MediaObjects/10549_2010_790_Fig1a-f_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-0790-6/MediaObjects/10549_2010_790_Fig1g-l_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-0790-6/MediaObjects/10549_2010_790_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-0790-6/MediaObjects/10549_2010_790_Fig3_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:124
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Fangfang Liu
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lifang Cui
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yang Zhang
               affiliation:
                     name:Fourth Military Medical University
                     address:
                        name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ling Chen
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yahong Wang
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu Fan
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ting Lei
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feng Gu
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ronggang Lang
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gordon A. Pringle
               affiliation:
                     name:Temple University Hospital
                     address:
                        name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinmin Zhang
               affiliation:
                     name:Temple University Hospital
                     address:
                        name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhinan Chen
               affiliation:
                     name:Fourth Military Medical University
                     address:
                        name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Li Fu
               affiliation:
                     name:Cancer Hospital of Tianjin Medical University
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma
      description:HAb18G is a recently identified hepatoma-associated antigen and its association with tumor growth, invasion, and angiogenesis has been studied in a variety of tumors. However, its role in the tumor progression of breast cancer has not been explored. HAb18G expression was examined by immunohistochemistry in pathological sections of 1,637 breast tissue samples and by in situ hybridization in 41 cases of invasive breast carcinomas (BC). While not detected in any cases of tumor-like conditions or benign tumors of breast, and only rarely in normal tissue (4.4%), HAb18G expression was gradually up-regulated from atypical ductal hyperplasia (27.3%), to ductal carcinoma-in situ (59.8%), and to BC (61.4%) (P < 0.01). Its expression in BC was correlated positively with C-erbB-2 expression and histologic grade (P < 0.001), and negatively with the expression of estrogen and progesterone receptors (P < 0.001). Significant differences of expression were also identified among the subgroups of BC examined: in decreasing order from invasive micropapillary carcinoma, ductal carcinoma, lobular carcinoma, papillary carcinoma, medullary carcinoma, to mucinous adenocarcinoma (P = 0.001), corresponding to their known clinical aggressiveness. In an expanded group of 186 BC patients with proper follow up, our previous findings were confirmed: HAb18G expression was significantly associated with local recurrence, distant metastasis and tumor mortality (P < 0.01). We also demonstrated that up-regulated tumor expression of HAb18G was a significant predictor of reduced disease progression-free survival rate and a shorter overall survival, independent of systemic therapies. In conclusion, this study suggests that HAb18G expression is associated with BC progression and prognosis. Further evaluation of this new marker in breast cancer is indicated.
      datePublished:2010-03-09T00:00:00Z
      dateModified:2010-03-09T00:00:00Z
      pageStart:677
      pageEnd:688
      sameAs:https://doi.org/10.1007/s10549-010-0790-6
      keywords:
         HAb18G
         Breast carcinoma
         Immunohistochemistry
         Tumor progression
         Prognosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-0790-6/MediaObjects/10549_2010_790_Fig1a-f_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-0790-6/MediaObjects/10549_2010_790_Fig1g-l_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-0790-6/MediaObjects/10549_2010_790_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-0790-6/MediaObjects/10549_2010_790_Fig3_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:124
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Fangfang Liu
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lifang Cui
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yang Zhang
            affiliation:
                  name:Fourth Military Medical University
                  address:
                     name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ling Chen
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yahong Wang
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu Fan
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ting Lei
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feng Gu
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ronggang Lang
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gordon A. Pringle
            affiliation:
                  name:Temple University Hospital
                  address:
                     name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinmin Zhang
            affiliation:
                  name:Temple University Hospital
                  address:
                     name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhinan Chen
            affiliation:
                  name:Fourth Military Medical University
                  address:
                     name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Li Fu
            affiliation:
                  name:Cancer Hospital of Tianjin Medical University
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:124
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
      name:Fourth Military Medical University
      address:
         name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
         type:PostalAddress
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
      name:Temple University Hospital
      address:
         name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
         type:PostalAddress
      name:Temple University Hospital
      address:
         name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
         type:PostalAddress
      name:Fourth Military Medical University
      address:
         name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
         type:PostalAddress
      name:Cancer Hospital of Tianjin Medical University
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Fangfang Liu
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Lifang Cui
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Yang Zhang
      affiliation:
            name:Fourth Military Medical University
            address:
               name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
               type:PostalAddress
            type:Organization
      name:Ling Chen
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Yahong Wang
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Yu Fan
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Ting Lei
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Feng Gu
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Ronggang Lang
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Gordon A. Pringle
      affiliation:
            name:Temple University Hospital
            address:
               name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Xinmin Zhang
      affiliation:
            name:Temple University Hospital
            address:
               name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Zhinan Chen
      affiliation:
            name:Fourth Military Medical University
            address:
               name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Li Fu
      affiliation:
            name:Cancer Hospital of Tianjin Medical University
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
      name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
      name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
      name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
      name:Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China
      name:Department of Breast Cancer Pathology and Research Laboratory, State Key Laboratory of Breast Cancer Research, Cancer Hospital of Tianjin Medical University, Tianjin, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(112)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.91s.